Pharma-Bio Serv (PBSV) Total Non-Current Liabilities (2017 - 2025)

Pharma-Bio Serv's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $1.7 million for Q3 2025.

• Quarterly Total Non-Current Liabilities changed N/A year-over-year to $1.7 million in Q3 2025, while the trailing twelve-month figure through Jul 2025 was $1.7 million (changed N/A YoY) and the FY2024 annual result came in at $1.9 million, changed N/A from the prior year.
• Total Non-Current Liabilities was $1.7 million for Q3 2025 at Pharma-Bio Serv, down from $1.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $8.9 million in Q1 2021 and bottomed at $1.7 million in Q3 2025.
• A 5-year average of $3.9 million and a median of $4.2 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities surged 77.42% — and 2022, when it plunged 50.81%.
• Pharma-Bio Serv's Total Non-Current Liabilities stood at $5.0 million in 2021, then sank by 50.81% to $2.5 million in 2022, then rose by 9.34% to $2.7 million in 2023, then dropped by 28.6% to $1.9 million in 2024, then fell by 13.42% to $1.7 million in 2025.
• Business Quant data shows PBSV's Total Non-Current Liabilities at $1.7 million in Q3 2025, $1.8 million in Q2 2025, and $1.9 million in Q4 2024.